English

Valera Pharmaceuticals Inc

EDGAR

Annual report (10-K) · filed 2007-02-22

5 filing records in this dataset, filed from 2006-03-20 to 2007-02-22. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.2 million USD

2006-12-31 · USD

Exact inputs and evidence

Revenue: 17966000 USD Source
Revenue: 14765000 USD Source

Operating margin

-149.52%

2006-12-31 · %

Exact inputs and evidence

Operating Income: -15087000 USD Source
Operating Income: -10301000 USD Source
Revenue: 17966000 USD Source
Revenue: 14765000 USD Source

Operating cash flow

-4.29 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -13711000 USD Source
Operating Cash Flow: -9421000 USD Source

Free cash flow

-4.81 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -13711000 USD Source
Operating Cash Flow: -9421000 USD Source
Capital Expenditure: 4221000 USD Source
Capital Expenditure: 3705000 USD Source

Cash and cash equivalents: 14.1 million USD 2006-12-31 Source
Exact value

14069000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Revenue: 5532000 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 6220000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 3013000 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 17966000 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 14765000 USD · 2006-01-01 – 2006-09-30 Source

Net income

-13.9 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Net income: -2112000 USD · 2006-01-01 – 2006-03-31 Source
Net income: -2742000 USD · 2006-04-01 – 2006-06-30 Source
Net income: -4684000 USD · 2006-07-01 – 2006-09-30 Source
Net income: -13939000 USD · 2006-01-01 – 2006-12-31 Source
Net income: -9538000 USD · 2006-01-01 – 2006-09-30 Source

Operating cash flow

-13.7 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: -970000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -5184000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -970000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -9421000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -5184000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -13711000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -9421000 USD · 2006-01-01 – 2006-09-30 Source

Capital expenditure

4.22 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Capital expenditure: 1589000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2614000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 1589000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 3705000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 2614000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 4221000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 3705000 USD · 2006-01-01 – 2006-09-30 Source

Free cash flow

-17.9 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: -970000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -5184000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -970000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -9421000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -5184000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -13711000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -9421000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 1589000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2614000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 1589000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 3705000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 2614000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 4221000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 3705000 USD · 2006-01-01 – 2006-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-02-22.

Financial data available through: 2006-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2006-12-31
Operating income: 4 of 11 periods available· newest 2006-12-31
Net income: 4 of 11 periods available· newest 2006-12-31
Operating cash flow: 4 of 11 periods available· newest 2006-12-31
Capital expenditure: 4 of 11 periods available· newest 2006-12-31
Total assets: 3 of 11 periods available· newest 2006-12-31
liabilities: No compatible figures in this window
Current assets: 3 of 11 periods available· newest 2006-12-31
Current liabilities: 3 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-33%

Prior period

USD 26.83 million

2005-01-01 – 2005-12-31
Current period

USD 17.97 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

17966000 − 26832000 = -8866000 USD

26832000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
17966000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Year-over-year change in Revenue: -8866000 USD Concept: fundies:Revenue Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 17966000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#5275 Input fundies:Revenue: 26832000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#5275
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 12.6 million

Prior period

−USD 1.34 million

2005-01-01 – 2005-12-31
Current period

−USD 13.94 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

-13939000 − -1344000 = -12595000 USD

-1344000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-13939000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Year-over-year change in Net income: -12595000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13939000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6361 Input fundies:NetIncome: -1344000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6361
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-4,944.9%

Prior period

USD 283,000

2005-01-01 – 2005-12-31
Current period

−USD 13.71 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

-13711000 − 283000 = -13994000 USD

283000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-13711000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Year-over-year change in Operating cash flow: -13994000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13711000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 Input fundies:OperatingCashFlow: 283000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+41.1%

Prior period

USD 2.99 million

2005-01-01 – 2005-12-31
Current period

USD 4.22 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

4221000 − 2992000 = 1229000 USD

2992000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
4221000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Year-over-year change in Capital expenditure: 1229000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4221000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 Input fundies:CapitalExpenditure: 2992000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2006-01-01 – 2006-12-31

Revenue USD 17.97 million 100% of revenue
Operating costs Derived USD 33.05 million 184% of revenue
Operating income −USD 15.09 million −84% of revenue
Tax, interest and other Derived −USD 1.15 million −6.4% of revenue
Net income −USD 13.94 million −78% of revenue

Cash

Operating cash flow −USD 13.71 million −76% of revenue
Capital expenditure USD 4.22 million 23% of revenue
Free cash flow Derived −USD 17.93 million −100% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Operating loss: operating costs were 108,243% of revenue.
2004 Operating loss: operating costs were 317% of revenue.
2005 Operating loss: operating costs were 105% of revenue.
2006 Operating loss: operating costs were 184% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	7000	7577000 Derived	-7570000	-13000 Derived	-7557000	-8055000 Derived	Source 2003-01-01 – 2003-12-31: 7000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -7570000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -7557000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -7907000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 148000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	5646000	17906000 Derived	-12260000	-237000 Derived	-12023000	-13752000 Derived	Source 2004-01-01 – 2004-12-31: 5646000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -12260000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -12023000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -12142000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 1610000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	26832000	28150000 Derived	-1318000	26000 Derived	-1344000	-2709000 Derived	Source 2005-01-01 – 2005-12-31: 26832000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -1318000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -1344000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 283000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2992000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	17966000	33053000 Derived	-15087000	-1148000 Derived	-13939000	-17932000 Derived	Source 2006-01-01 – 2006-12-31: 17966000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -15087000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -13939000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -13711000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 4221000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 18M 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	7000	Revenue: 7000 Open source
20042004-12-31	Revenue	5646000	Revenue: 5646000 Open source
20052005-12-31	Revenue	26832000	Revenue: 26832000 Open source
20062006-12-31	Revenue	17966000	Revenue: 17966000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-33% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	No prior comparable period	Revenue: 7000 Open source
20042004-12-31	Year over year	80,557.1%	Revenue: 5646000 Open source Revenue: 7000 Open source
20052005-12-31	Year over year	375.2%	Revenue: 26832000 Open source Revenue: 5646000 Open source
20062006-12-31	Year over year	-33%	Revenue: 17966000 Open source Revenue: 26832000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -84% 2006

Net margin -77.6% 2006

Free cash flow margin -99.8% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	-108,142.9%	Operating Income: -7570000 Open source Revenue: 7000 Open source
20042004-12-31	Operating margin	-217.1%	Operating Income: -12260000 Open source Revenue: 5646000 Open source
20052005-12-31	Operating margin	-4.9%	Operating Income: -1318000 Open source Revenue: 26832000 Open source
20062006-12-31	Operating margin	-84%	Operating Income: -15087000 Open source Revenue: 17966000 Open source
20032003-12-31	Net margin	-107,957.1%	Net Income: -7557000 Open source Revenue: 7000 Open source
20042004-12-31	Net margin	-212.9%	Net Income: -12023000 Open source Revenue: 5646000 Open source
20052005-12-31	Net margin	-5%	Net Income: -1344000 Open source Revenue: 26832000 Open source
20062006-12-31	Net margin	-77.6%	Net Income: -13939000 Open source Revenue: 17966000 Open source
20032003-12-31	Free cash flow margin	-115,071.4%	Revenue: 7000 Open source Operating Cash Flow: -7907000 Open source Capital Expenditure: 148000 Open source
20042004-12-31	Free cash flow margin	-243.6%	Revenue: 5646000 Open source Operating Cash Flow: -12142000 Open source Capital Expenditure: 1610000 Open source
20052005-12-31	Free cash flow margin	-10.1%	Revenue: 26832000 Open source Operating Cash Flow: 283000 Open source Capital Expenditure: 2992000 Open source
20062006-12-31	Free cash flow margin	-99.8%	Revenue: 17966000 Open source Operating Cash Flow: -13711000 Open source Capital Expenditure: 4221000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.7M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-7907000	Operating Cash Flow: -7907000 Open source
20042004-12-31	Operating cash flow	-12142000	Operating Cash Flow: -12142000 Open source
20052005-12-31	Operating cash flow	283000	Operating Cash Flow: 283000 Open source
20062006-12-31	Operating cash flow	-13711000	Operating Cash Flow: -13711000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -17.9M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	-8055000	Operating Cash Flow: -7907000 Open source Capital Expenditure: 148000 Open source
20042004-12-31	Free cash flow	-13752000	Operating Cash Flow: -12142000 Open source Capital Expenditure: 1610000 Open source
20052005-12-31	Free cash flow	-2709000	Operating Cash Flow: 283000 Open source Capital Expenditure: 2992000 Open source
20062006-12-31	Free cash flow	-17932000	Operating Cash Flow: -13711000 Open source Capital Expenditure: 4221000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	Total Assets: 13667000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 16532000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 31965000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.97× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Current assets / current liabilities	Not reported	No source recorded
20042004-12-31	Current assets / current liabilities	3.3×	Current Assets: 11918000 Open source Current Liabilities: 3612000 Open source
20052005-12-31	Current assets / current liabilities	1.36×	Current Assets: 10745000 Open source Current Liabilities: 7900000 Open source
20062006-12-31	Current assets / current liabilities	3.97×	Current Assets: 23518000 Open source Current Liabilities: 5921000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 7.56 million Exact value Exact value: -7557000 USD 2003-01-01 – 2003-12-31: -7557000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Valera Pharmaceuticals Inc · 2003-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Net Income: -7557000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7557000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0000893220-06-000625.txt#13701 The citation records this snapshot. The page link may show a newer release later.	−USD 7.91 million Exact value Exact value: -7907000 USD 2003-01-01 – 2003-12-31: -7907000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Valera Pharmaceuticals Inc · 2003-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Operating Cash Flow: -7907000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7907000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0000893220-06-000625.txt#14063 The citation records this snapshot. The page link may show a newer release later.	USD 148,000 Exact value Exact value: 148000 USD 2003-01-01 – 2003-12-31: 148000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Valera Pharmaceuticals Inc · 2003-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Capital Expenditure: 148000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 148000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0000893220-06-000625.txt#14101 The citation records this snapshot. The page link may show a newer release later.	−USD 8.06 million Calculation and evidence -7907000 − 148000 USD Exact free cash flow: -8055000 USD 2003-01-01 – 2003-12-31: -7907000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 148000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Valera Pharmaceuticals Inc · 2003-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Free cash flow: -8055000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7907000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0000893220-06-000625.txt#14063 Input fundies:CapitalExpenditure: 148000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0000893220-06-000625.txt#14101 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 12.02 million Exact value Exact value: -12023000 USD 2004-01-01 – 2004-12-31: -12023000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Valera Pharmaceuticals Inc · 2004-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Net Income: -12023000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12023000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6361 The citation records this snapshot. The page link may show a newer release later.	−USD 12.14 million Exact value Exact value: -12142000 USD 2004-01-01 – 2004-12-31: -12142000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Valera Pharmaceuticals Inc · 2004-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Operating Cash Flow: -12142000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12142000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Exact value Exact value: 1610000 USD 2004-01-01 – 2004-12-31: 1610000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Valera Pharmaceuticals Inc · 2004-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Capital Expenditure: 1610000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1610000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.	−USD 13.75 million Calculation and evidence -12142000 − 1610000 USD Exact free cash flow: -13752000 USD 2004-01-01 – 2004-12-31: -12142000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 1610000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Valera Pharmaceuticals Inc · 2004-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Free cash flow: -13752000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12142000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 Input fundies:CapitalExpenditure: 1610000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 1.34 million Exact value Exact value: -1344000 USD 2005-01-01 – 2005-12-31: -1344000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Valera Pharmaceuticals Inc · 2005-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Net Income: -1344000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1344000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6361 The citation records this snapshot. The page link may show a newer release later.	USD 283,000 Exact value Exact value: 283000 USD 2005-01-01 – 2005-12-31: 283000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Valera Pharmaceuticals Inc · 2005-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Operating Cash Flow: 283000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 283000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 The citation records this snapshot. The page link may show a newer release later.	USD 2.99 million Exact value Exact value: 2992000 USD 2005-01-01 – 2005-12-31: 2992000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Valera Pharmaceuticals Inc · 2005-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Capital Expenditure: 2992000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2992000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.	−USD 2.71 million Calculation and evidence 283000 − 2992000 USD Exact free cash flow: -2709000 USD 2005-01-01 – 2005-12-31: 283000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2992000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Valera Pharmaceuticals Inc · 2005-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Free cash flow: -2709000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 283000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 Input fundies:CapitalExpenditure: 2992000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 13.94 million Exact value Exact value: -13939000 USD 2006-01-01 – 2006-12-31: -13939000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Net Income: -13939000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13939000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6361 The citation records this snapshot. The page link may show a newer release later.	−USD 13.71 million Exact value Exact value: -13711000 USD 2006-01-01 – 2006-12-31: -13711000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Operating Cash Flow: -13711000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13711000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 The citation records this snapshot. The page link may show a newer release later.	USD 4.22 million Exact value Exact value: 4221000 USD 2006-01-01 – 2006-12-31: 4221000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Capital Expenditure: 4221000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4221000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.	−USD 17.93 million Calculation and evidence -13711000 − 4221000 USD Exact free cash flow: -17932000 USD 2006-01-01 – 2006-12-31: -13711000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 4221000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Valera Pharmaceuticals Inc · 2006-12-31 Valera Pharmaceuticals Inc (edgar:1305409) Free cash flow: -17932000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-11T14:40:09Z Snapshot: f640f670c6fb604907411a661119558d698e9e4caae974ee53b7483ab35e1a07 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1305409?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13711000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6613 Input fundies:CapitalExpenditure: 4221000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1305409/0001193125-07-036846.txt#6641 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

5 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-11. Source filing dates and reporting periods are shown separately.

Identifiers: 0001305409, 1305409, edgar:1305409

Valera Pharmaceuticals Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2006-01-01 – 2006-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation